FDA data Registry peer set 1 peer

Alternatives to pramipexole

1 same-class SPL records vs pramipexole - uses, FAERS reaction fields, and OTC/Rx flags from public FDA sources.

Brand: Mirapex

Dopamine Agonist Prescription 1 alternative found

About pramipexole

Pramipexole extended-release tablets help treat Parkinson's disease. It belongs to a class of drugs called dopamine agonists.

Used for: This medicine treats Parkinson's disease. Parkinson's affects movement, causing stiffness, tremors, and slow motion. Pramipexole can help control these symptoms, so you can move more easily.

1 Dopamine Agonist peers (wide set)

Compare pramipexole vs ropinirole side-by-side →

pramipexole vs ropinirole · FAERS reaction fields

FAERS top-reaction field "Condition Aggravated" shows the widest count spread between pramipexole and ropinirole in this extract (300-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.

Side Effect pramipexole ropinirole
Fall 1,066 1,004
Fatigue 1,043 920
Nausea 832 852
Pain 795 630
Condition Aggravated 788 488
Hallucination 754 711
Dizziness 734 721
Dyspnoea 710 591

"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.

pramipexole peer mix vs class inventory

Peer mix

0 OTC and 1 Rx SPL records in this peer set (1 total). Class inventory for Dopamine Agonist: 2 drugs.

Frequently Asked Questions

What same-class SPL records sit beside pramipexole?
This registry lists 1 Dopamine Agonist medication records beside pramipexole, including ropinirole. Grouping is therapeutic-class indexing from openFDA/SPL, not a product recommendation.

Reading a wide Dopamine Agonist peer set (1 records)

pramipexole (Mirapex) sits in a wide Dopamine Agonist peer set (1 of 1 class peers shown). Labeled indication field for pramipexole: This medicine treats Parkinson's disease.

Top FAERS reaction fields for pramipexole total 8,007 reports across 10 reactions, set beside ropinirole. Counts are exposure-weighted submissions, not per-patient risk.

Registry note: Therapeutic-class peer lists are registry indexes, not prescribing advice. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.

Full pramipexole profile →

Field note for pramipexole: see also the generic vs brand label guide when reading Mirapex SPL strings.